ScrutarSign up free

Humacyte, Inc. (HUMA)

SEC filings, insider trading & institutional ownership from EDGAR.

NasdaqHealth CareBiotechnology
Institutions
30
$27.52B held

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →

No filings are available yet.

Top holders

13F & 13D/G · latest quarter

All →
HolderFiledValue
Vanguard Capital ManagementAug 13, 2026$7.88B
BlackRock, Inc.Aug 7, 2026$3.78B
SUSQUEHANNA INTERNATIONAL GROUP, LLPAug 14, 2026$2.25B
UBS Group AGAug 13, 2026$2.22B
AQR CAPITAL MANAGEMENT LLCAug 14, 2026$2.03B

HUMA's filings are public. The insight is one click away.

Scrutar's AI reads every HUMA filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze HUMA filingsNo credit cardAI reports included on the free plan

Never miss a HUMA filing.

Get an email when HUMA files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Aug 30, 2026Source: SEC EDGAR.